Acute Leukemias Flashcards

1
Q

Fever, Fatigue, Shortness of Breath, and Nosebleed are common symptoms of ACUTE leukemias. What is the root cause of each of these symptoms?

A

Fever:
• Neutropenia

Nose Bleed:
• Low Platelets

Fatigue, Shortness of Breath:
• Low RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T or F: acute myeloid leukemias and acute lymphoid leukemias can easily be differentiated by review of the peripheral smear.

A

False, while there are some fairly obvious cases (Auer bodies) rarely you can be definitive by looking alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What age are you statistically least likely to get an acute lymphocytic leukemia?
• What about an acute myelocytic leukemia?

A

ALL:
11-39 years old

Incidence is highest:
3-7 and dropping off by age 10
Second rise is seen at age 40

AML:
Seen in all age groups and becomes increasingly common with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the defining difference between Primary AML and secondary AML?
• Which is more difficult to treat?
• Why?

A

Secondary AML developes from Myelodysplastic Syndromes or other Hematologic Malignancies meaning there are more mutations present and its an OLDER INDIVIDUAL

Primary AML arrises de novo and is usually in younger people who are more resilient to the treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T or F: smoking is a major cause of Acute Myeloid Leukemia.

A

False, smoking is not a cause of AML but does cause some types of CML.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T or F: the vast majority of AMLs are idiopathic.

A

True, other common causes include:

  • Chemo/Radiotherapy
  • PNH/Aplastic Anemias
  • Myelodysplastic/Myeloproliferative Syndromes
  • Down’s Syndroms
  • Chemical Exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

For AML and ALLs where do we see the mutations that cause malignancy arising?

A

Mutations Typically occur in Hematopoetic Stem Cells or in early progenitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is acute leukemia defined?

A

The Presence of Over 20% blast cells in the blood or bone marrow

***Specific CYTOGENETIC or MOLECULAR genetic abnormalities may allow it to be Dx. at a lower threshold.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HOW DO HEMOTOLOGISTS KNOW WHETHER A CANCER IS AN AML OR ALL?

A

IMMUNOPHENOTYPING can be used to tell us which we are dealing with.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T or F: the presence of Auer rods is DIAGNOSTIC of AML.

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are 4 myeloid antigens?

A
  • MPO
  • CD33
  • CD13
  • HLA-DR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 4 lymphoid antigens?

A
  • TdT
  • CD10
  • CD19
  • CD20
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When reading a CBC think about whether you’re dealing with a pancytopenia.

A

When reading a CBC think about whether you’re dealing with a pancytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the point of giving of giving a patient with t(15,17) ATRA and Arsenic?

A

ALLOWS FOR CELL DIFFERENTIATION

ATRA - binds to the PML-RARA protein and helps unbind it from DNA

Arsenic - does the same but acts on K160 of PML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 3 stages of therapy in AML?

A

Remission Induction Therapy:
• 1 to 2 courses of intensive therapy to achieve a complete response (NO leukemia cells detectable)

Post-remission therapy:
• 3 to 4 courses of intensive short-courses to get what we can’t see

SOME PTS:

  • maintenance therapy lasting Months or Years (less intense) OR
  • Allogeneic Bone Marrow Transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What treatment strategies might you consider for older adults with AML?

A
  • Supportive Care
  • New noncytoxic agents with less side effects
  • Reduced intensity (HSCT) - bone marrow transplant

Probably would avoid standard intensive chemotherapy because it can be toxic and the response usually isn’t great

17
Q

T or F: in both adult and childhood ALL, the MLL-AF4 and BCR-ABL are associated with poor outcome

A

True

18
Q

What are some things that we must do differently in the stages of therapy for ALL vs. AML?

A

ALL:

  • Remission Induction
  • Consolidation
  • Maintenance

Differences:

  • *Maintenance is more commonly needed in ALL
  • *Allopurinol needed to prevent Tumor Lysis Syndrome
  • *CNS PROPHYLAXIS NEEDED
19
Q

Between AML and ALL, which requires CNS prophylaxis?

• Why?

A

ALL - need CNS prophylaxis via intrathecal injection because cancer more commonly spreads here in ALL than AML

20
Q

What is the cure rate in children and in adults with ALL?

• how do we account for this difference?

A

Children: 75-80% cure rate
Adults: 40%

Difference may be attributed to worse genetic features present in genome when adult acquire it

21
Q

What type of testing is the best prognostic indicator?

A

Genetic Testing

22
Q

Which would you tailor therapy bases on a FLT3 mutation AML or ALL?

A

AML